KEGG: esa:ESA_00941
STRING: 290339.ESA_00941
Based on pan-genome analyses of 237 C. sakazakii genomes, approximately 19.5% of the 17,158 orthologous gene clusters constitute the core genome . The respiratory chain components, including NADH-quinone oxidoreductase complexes, are typically highly conserved due to their essential metabolic functions. Given that functions involved in proton transport are enriched in C. sakazakii strains, it is likely that nuoK belongs to the core genome, though specific confirmation would require targeted genomic analysis comparing this gene across all sequenced strains.
The NADH-quinone oxidoreductase complex, including nuoK, plays a critical role in bacterial energy metabolism. C. sakazakii demonstrates remarkable adaptability across diverse environmental conditions, including temperature ranges from 4°C to 50°C . The respiratory complex containing nuoK likely contributes to this adaptability through:
Maintenance of proton motive force under stress conditions
Energy production adaptability during niche switching (environmental to host)
Metabolic flexibility when encountering different carbon sources
This adaptability may partially explain why C. sakazakii can thrive in diverse settings from powdered infant formula to the human host environment.
For membrane proteins like nuoK, the expression system selection is critical:
| Expression System | Advantages | Limitations | Best For |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid growth | Potential misfolding of membrane proteins | Initial screening, mutagenesis studies |
| Bacillus subtilis | Natural Gram-positive secretion, reduced inclusion bodies | Lower yields than E. coli | Structural studies requiring proper folding |
| Cell-free systems | Avoids toxicity issues, direct access to reaction | Expensive, limited scalability | Difficult-to-express proteins, rapid screening |
| Yeast (P. pastoris) | Post-translational modifications, proper folding | Longer expression time | Studies requiring eukaryotic-like processing |
Based on similar membrane protein studies and approaches used for H. pylori nuoK , an E. coli-based expression system with an N-terminal His-tag appears to be a practical starting point, with codon optimization for C. sakazakii sequences.
Membrane proteins like nuoK require specific approaches to verify structural integrity:
Circular dichroism (CD) spectroscopy to assess secondary structure composition
Limited proteolysis to evaluate proper folding
Thermal shift assays to determine stability
Functional reconstitution in liposomes followed by activity assays (measuring NADH oxidation)
Size-exclusion chromatography with multi-angle light scattering (SEC-MALS) to verify oligomeric state
When interpreting results, researchers should consider that recombinant nuoK may behave differently compared to the native protein complex due to the absence of other respiratory complex subunits.
Recombination has significantly shaped the C. sakazakii genome, with approximately 53.3% of the genome showing evidence of recombination history . For metabolic genes like nuoK, several patterns have been observed:
The mean fragment size of recombination events in C. sakazakii is 815.559 bp (s.d. = 80.203)
The relative rate of recombination to mutation (γ/μ) is estimated at 1.6054 (s.d. = 0.04224)
Genes associated with metabolic functions are among the most frequently recombined
To specifically analyze nuoK evolution, researchers should:
Perform phylogenetic analysis of nuoK sequences across Cronobacter species
Calculate dN/dS ratios to identify selection pressures
Apply recombination detection algorithms (e.g., PHI test, which detected significant recombination in C. sakazakii core genome, p-value = 0.0)
Use correlation profiles to identify recombination-derived sequence blocks
Experimental designs examining nuoK should account for potential evolutionary mosaicism resulting from this recombination history.
For comprehensive analysis of nuoK variation across C. sakazakii isolates, the following bioinformatic pipeline is recommended:
Sequence Acquisition: Extract nuoK sequences from the 386+ whole genome sequences available
Multiple Sequence Alignment: Implement MAFFT alignment as performed in phylogenetic analyses of Cronobacter
Diversity Analysis:
Calculate nucleotide diversity (π)
Identify single nucleotide polymorphisms (SNPs)
Detect insertion/deletion events
Structural Mapping: Map variants to predicted structural models
Recombination Detection: Apply methods such as:
Comparative Analysis: Compare nuoK diversity patterns with other respiratory chain components
Based on the observed C. sakazakii genomic diversity patterns, researchers should anticipate significant sequence variation across isolates from different ecological niches (clinical vs. environmental) .
The functional characterization of nuoK requires multiple complementary approaches:
When analyzing results, researchers should consider the growth characteristics of C. sakazakii, which include mean generation times that vary by temperature and media composition, with C. sakazakii showing shorter generation times in powdered infant formula compared to tryptone soya broth .
To map the interaction network of nuoK within the respiratory complex:
Cross-linking Mass Spectrometry (XL-MS):
Apply membrane-permeable cross-linkers to intact C. sakazakii cells
Isolate the respiratory complex
Perform tryptic digestion and analyze cross-linked peptides by LC-MS/MS
Map interaction sites between nuoK and partner proteins
Co-purification Studies:
Express tagged nuoK in C. sakazakii
Perform membrane solubilization using mild detergents
Isolate protein complexes via affinity chromatography
Identify interacting partners by mass spectrometry
Cryo-EM Analysis:
Purify intact respiratory complex containing nuoK
Determine structure by cryo-electron microscopy
Localize nuoK within the complex architecture
Complementary in silico Approaches:
Homology modeling based on related bacterial respiratory complexes
Molecular dynamics simulations to predict stable interaction interfaces
Coevolution analysis to identify co-evolving residues
These studies should be interpreted in light of C. sakazakii's genomic plasticity and frequent recombination, which may influence protein-protein interaction networks between strains .
While the direct contribution of nuoK to C. sakazakii pathogenicity remains to be fully characterized, respiratory chain components may enhance pathogenicity through:
Energy Production for Virulence Factor Expression: Supporting the energetic requirements for producing virulence factors (including those associated with chemotaxis, enterobactin synthesis, type VI secretion system)
Adaptation to Host Environment: Enabling metabolic flexibility within the host, particularly through proton transport mechanisms that were found to be enriched in human-derived strains
Stress Response: Supporting survival under stress conditions within the host
Biofilm Formation: Providing energy for biofilm development, which enhances resistance to antimicrobials and host defenses
Research approaches to investigate these connections should include:
Comparative transcriptomics of nuoK expression during infection vs. environmental conditions
Testing of nuoK mutants in cellular infection models
Analysis of nuoK sequence variations between clinical and environmental isolates
The respiratory chain represents a potential antimicrobial target, and structural studies of nuoK could inform drug development:
Target Validation Approach:
Express and purify recombinant nuoK for structural studies
Determine high-resolution structure using X-ray crystallography or cryo-EM
Identify potential binding pockets unique to bacterial nuoK
Screen compound libraries against purified nuoK
Key Methodological Considerations:
Membrane proteins like nuoK require specialized approaches for structural determination
Detergent selection is critical for maintaining native-like structure
Crystal contacts are challenging to form with transmembrane regions
Nanodiscs or amphipols may provide more native-like membrane environments
Specificity Determination:
Given that C. sakazakii carries various antibiotic resistance genes, including fosfomycin resistance (fos) and multidrug efflux transporter mdf(A) , novel antimicrobial targets like nuoK may offer alternative therapeutic approaches.